0001209191-23-040283.txt : 20230630 0001209191-23-040283.hdr.sgml : 20230630 20230630160013 ACCESSION NUMBER: 0001209191-23-040283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nakanishi Xin CENTRAL INDEX KEY: 0001778209 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 231061539 MAIL ADDRESS: STREET 1: C/O ONCTERNAL THERAPEUTICS, INC. STREET 2: 3525 DEL MAR HEIGHTS ROAD #821 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-28 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001778209 Nakanishi Xin 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 1 0 0 0 0 Stock Options 0.3553 2023-06-28 4 A 0 25000 0.00 A 2033-06-28 Common Stock 25000 25000 D One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date. /s/Chase C. Leavitt, Attorney-in-fact 2023-06-30